Emerging Pharmacological and Immunotherapeutic Strategies in Celiac Disease: From Mechanisms to Clinical Translation
Biosciences Biotechnology Research Asia · 26.06.2026 · 2 (23) · 479
DOI: 10.13005/bbra/3513 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biosciences Biotechnology Research Asia, online erschienen am 25.06.2026. Verfasst von Amol Tonde und 1 weiteren Autor:innen. Die Arbeit nennt 186 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
In genetically susceptible individuals, gluten intake leads to celiac disease (CD), a chronic immune-related enteropathy that results in villous atrophy, intestinal inflammation, and malabsorption. It marks roughly 0.7%–1.4% of the global populace, with occurrence growing over time. Presently, the single accepted cure is a strict, lifelong gluten-free diet (GFD); nevertheless, this approach is hard to manage, carries risks of hidden gluten exposure, and cannot wholly alleviate symptoms or prevent intestinal impairment in all patients. Recent developments have driven the progress of several emerging therapeutic strategies. These comprise gluten-degrading enzymes designed to detoxify immunogenic peptides, pharmacological agents such as tight-junction regulators and transglutaminase inhibitors that target intestinal permeability and antigen modification, as well as immune-modulating therapies aimed at reducing pathological immune responses. Additionally, microbiome-based interventions are being explored to restore gut homeostasis and support immune regulation. Nutraceuticals and vaccine-based methods are two complementary therapies that are being researched. This review emphasizes an executive summary of the background and pathophysiology of celiac disease, highlights the limitations of the GFD, and focuses on recent advancements in enzyme therapy, pharmacological treatments, and immunotherapies. Furthermore, it discusses ongoing clinical trials (CT) and future perspectives, emphasizing the potential of these novel approaches to transform disease management beyond dietary restriction.
Zitieren
APA
Tonde, A., & Chhajed, S. (2026). Emerging Pharmacological and Immunotherapeutic Strategies in Celiac Disease: From Mechanisms to Clinical Translation. Biosciences Biotechnology Research Asia, 2(23), 479. https://doi.org/10.13005/bbra/3513
Vancouver
Tonde A, Chhajed S. Emerging Pharmacological and Immunotherapeutic Strategies in Celiac Disease: From Mechanisms to Clinical Translation. Biosciences Biotechnology Research Asia. 2026;2(23):479. doi:10.13005/bbra/3513
BibTeX
@article{Tonde2026,
author = {Tonde, Amol and Chhajed, Santosh},
title = {Emerging Pharmacological and Immunotherapeutic Strategies in Celiac Disease: From Mechanisms to Clinical Translation},
journal = {Biosciences Biotechnology Research Asia},
year = {2026},
volume = {2},
number = {23},
pages = {479},
doi = {10.13005/bbra/3513}
}
EUVIMED